Similar Search Results

Costs and benefits of branded drugs : insights from cost-effectiveness research

Frech, Henry Edward; Pauly, Mark V.; Comanor, William S.; … - In: Journal of benefit-cost analysis : JBCA 13 (2022) 2, pp. 166-181

The relationship between costs and health benefits of branded pharmaceuticals remains controversial. This paper examines the incremental costs incurred for incremental health benefits gained from the largest available sample of cost-effectiveness studies of branded drugs in the USA, the...

Persistent link: https://www.econbiz.de/10013366987

The United States

Frech, Henry Edward - In: Advances in health economics and health services … 1 (1990), pp. 43-75

Persistent link: https://www.econbiz.de/10001338003

Market power, transactions costs, and the entry of accountable care organizations in health care

Frech, Henry Edward; Whaley, Christopher; Handel, … - In: Review of industrial organization : RIO 47 (2015) 2, pp. 167-193

Persistent link: https://www.econbiz.de/10011350656

Value based pricing of pharmaceuticals in the US and UK : does centralized cost effectiveness analysis matter?

Comanor, William S.; Schweitzer, Stuart O.; Riddle, Jon M. - In: Review of industrial organization : RIO 52 (2018) 4, pp. 589-602

Persistent link: https://www.econbiz.de/10012008043

U.S. pharmaceutical markets : expenditures, health insurance, new products and generic prescribing from 1960 to 2016

Lu, Z. John; Comanor, William S.; Cherkas, Elliot; … - In: International journal of the economics of business 27 (2020) 1, pp. 1-26

Persistent link: https://www.econbiz.de/10012182277

National health insurance in Ontario : the effects of a policy of cost control

Comanor, William S. - 1980

Persistent link: https://www.econbiz.de/10000338188